The Latest Cardiac and Vascular News
November 2, 2021 Philips debuts three new solutions in the North American market that will help drive procedural innovation and workflow efficiency, adding to the company’s ecosystem of interventional imaging systems, and diagnostic and therapeutic devices New clinical data presented at TCT 2021: five-year outcomes of iFR-SWEDEHEART trial and new large-scale […]
SOUTH SAN FRANCISCO, Calif., Nov. 01, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on October 29, 2021 it granted stock options to purchase an aggregate of 68,550 shares of common stock to 8 new employees, whose employment commenced in October 2021, as a material inducement to […]
– Recently Announced Transformative Plan to Align Operational and Expense Structure to the Current Environment and Position for Long-Term Growth – – Unprecedented CLEAR Outcomes Study Remains On-Track for Complete Major Adverse Cardiac Events (MACE) Accumulation in 2H 2022; Achieved 80% MACE Accumulation in October – – U.S. Net Product Revenue […]
Vivek Walimbe, Ph.D., former VP for Baxter Healthcare, to lead development of intracoronary imaging product and expand portfolio Farzad Parsaie, with three decades of med device leadership, to oversee Quality and Regulatory Affairs BEDFORD, Mass.–(BUSINESS WIRE)–SpectraWAVE, Inc., a pre-commercial medical imaging company focused on optical and computational insights for the […]
HU6 was well tolerated and increased resting energy expenditure Dose dependent weight loss and an improvement in metabolic parameters were also observed, despite the study not being powered to demonstrate them Enrollment for a Phase 2a Metabolic Trial of HU6 has completed with topline data expected in Q1 2022 HU6 […]
David Seth Feldman, MD, PhD, FACC, FAHA, named new Section Chief of Advanced Heart Failure Treatment and Transplantation NEWARK, N.J., Nov. 1, 2021 /PRNewswire/ — Newark Beth Israel Medical Center, an RWJBarnabas Health facility, has named David Seth Feldman, MD, PhD, FACC, FAHA, the new Section Chief of Advanced Heart Failure Treatment and Transplantation. […]
Breakthrough CCM Therapy Now Being Implemented in China MARLTON, N.J., Nov. 01, 2021 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure, today announced the first implantation of a patient in China with its innovative Optimizer system delivering CCM […]
The Company reports increased adoption and commercial activity of its signal processing technology for arrhythmia care Westport, CT, Nov. 01, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover […]
BOULDER, Colo., Nov. 01, 2021 (GLOBE NEWSWIRE) — SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a strategic collaboration with one of the nation’s leading academic medical centers, University Hospitals Cleveland Medical Center, where they will evaluate the impact of the company’s SomaSignal™ tests on the medical […]
BAINBRIDGE ISLAND, Wash.–(BUSINESS WIRE)–ReValve Solutions, Inc., an innovator in the field of transcatheter structural heart replacement and repair, announced today it has successfully completed the first human use of its transcatheter, Palmetto System for mitral valve replacement. The patient was successfully treated who suffered from severe mitral valve regurgitation and […]
